APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crohn’s Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Crohn’s Disease Treatment Market Outlook and Growth Opportunities 2026

21 December 2025195 pages

Choose your research edition.

Industry ResearchCrohn’s Disease Treatment Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Crohn’s Disease Treatment Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Crohn’s Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crohn’s Disease Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Crohn’s Disease Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Crohn’s Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Crohn’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Crohn’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crohn’s Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Crohn’s Disease Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Crohn’s Disease Treatment market include Takeda Pharmaceutical Ltd, Johnson & Johnson, Roche, Pfizer Inc., Biogen, Bristol Myers Squibb, Abbvie Inc., AstraZeneca and Prometheus Laboratories Inc. (Nestle), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Crohn’s Disease Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Crohn’s Disease Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Crohn’s Disease Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Crohn’s Disease Treatment market.

Crohn’s Disease Treatment Segment by Company

Takeda Pharmaceutical Ltd

Johnson & Johnson

Roche

Pfizer Inc.

Biogen

Bristol Myers Squibb

Abbvie Inc.

AstraZeneca

Prometheus Laboratories Inc. (Nestle)

Bausch Health

Crohn’s Disease Treatment Segment by Type

Corticosteroids

Immunomodulators

Antibiotics

Amino Salicylates

Others

Crohn’s Disease Treatment Segment by Application

Hospitals

Specialty Clinics

Other

Crohn’s Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Crohn’s Disease Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Crohn’s Disease Treatment key companies, revenue, market share, and recent developments.

3. To split the Crohn’s Disease Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Crohn’s Disease Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Crohn’s Disease Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Crohn’s Disease Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Crohn’s Disease Treatment industry.

Chapter 3: Detailed analysis of Crohn’s Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Crohn’s Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Crohn’s Disease Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Crohn’s Disease Treatment Industry Trends Table 2. Crohn’s Disease Treatment Industry Drivers Table 3. Crohn’s Disease Treatment Industry Opportunities and Challenges Table 4. Crohn’s Disease Treatment Industry Restraints Table 5. Global Crohn’s Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Crohn’s Disease Treatment Revenue Share by Company (2021-2026) Table 7. Global Crohn’s Disease Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Crohn’s Disease Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Crohn’s Disease Treatment Company, Product Type & Application Table 10. Global Crohn’s Disease Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Crohn’s Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Corticosteroids Table 15. Significant Companies of Immunomodulators Table 16. Significant Companies of Antibiotics Table 17. Significant Companies of Amino Salicylates Table 18. Significant Companies of Others Table 19. Global Crohn’s Disease Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Crohn’s Disease Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Crohn’s Disease Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Crohn’s Disease Treatment Sales Value Share by Type (2021-2026) Table 23. Global Crohn’s Disease Treatment Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Specialty Clinics Table 26. Significant Companies of Other Table 27. Global Crohn’s Disease Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Crohn’s Disease Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Crohn’s Disease Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Crohn’s Disease Treatment Sales Value Share by Application (2021-2026) Table 31. Global Crohn’s Disease Treatment Sales Value Share by Application (2027-2032) Table 32. Global Crohn’s Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Crohn’s Disease Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Crohn’s Disease Treatment Sales Value Share by Region (2021-2026) Table 35. Global Crohn’s Disease Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Crohn’s Disease Treatment Sales Value Share by Region (2027-2032) Table 37. Global Crohn’s Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Crohn’s Disease Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Crohn’s Disease Treatment Sales Value Market Share by Country (2021-2026) Table 40. Global Crohn’s Disease Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Crohn’s Disease Treatment Sales Value Market Share by Country (2027-2032) Table 42. Takeda Pharmaceutical Ltd Company Information Table 43. Takeda Pharmaceutical Ltd Business Overview Table 44. Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Product Portfolio Table 46. Takeda Pharmaceutical Ltd Recent Development Table 47. Johnson & Johnson Company Information Table 48. Johnson & Johnson Business Overview Table 49. Johnson & Johnson Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Johnson & Johnson Crohn’s Disease Treatment Product Portfolio Table 51. Johnson & Johnson Recent Development Table 52. Roche Company Information Table 53. Roche Business Overview Table 54. Roche Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Roche Crohn’s Disease Treatment Product Portfolio Table 56. Roche Recent Development Table 57. Pfizer Inc. Company Information Table 58. Pfizer Inc. Business Overview Table 59. Pfizer Inc. Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Pfizer Inc. Crohn’s Disease Treatment Product Portfolio Table 61. Pfizer Inc. Recent Development Table 62. Biogen Company Information Table 63. Biogen Business Overview Table 64. Biogen Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Biogen Crohn’s Disease Treatment Product Portfolio Table 66. Biogen Recent Development Table 67. Bristol Myers Squibb Company Information Table 68. Bristol Myers Squibb Business Overview Table 69. Bristol Myers Squibb Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Bristol Myers Squibb Crohn’s Disease Treatment Product Portfolio Table 71. Bristol Myers Squibb Recent Development Table 72. Abbvie Inc. Company Information Table 73. Abbvie Inc. Business Overview Table 74. Abbvie Inc. Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Abbvie Inc. Crohn’s Disease Treatment Product Portfolio Table 76. Abbvie Inc. Recent Development Table 77. AstraZeneca Company Information Table 78. AstraZeneca Business Overview Table 79. AstraZeneca Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. AstraZeneca Crohn’s Disease Treatment Product Portfolio Table 81. AstraZeneca Recent Development Table 82. Prometheus Laboratories Inc. (Nestle) Company Information Table 83. Prometheus Laboratories Inc. (Nestle) Business Overview Table 84. Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Product Portfolio Table 86. Prometheus Laboratories Inc. (Nestle) Recent Development Table 87. Bausch Health Company Information Table 88. Bausch Health Business Overview Table 89. Bausch Health Crohn’s Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Bausch Health Crohn’s Disease Treatment Product Portfolio Table 91. Bausch Health Recent Development Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Crohn’s Disease Treatment Product Image Figure 2. Global Crohn’s Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crohn’s Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Crohn’s Disease Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Corticosteroids Image Figure 8. Immunomodulators Image Figure 9. Antibiotics Image Figure 10. Amino Salicylates Image Figure 11. Others Image Figure 12. Global Crohn’s Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Crohn’s Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Crohn’s Disease Treatment Sales Value Share by Type (2021-2032) Figure 15. Hospitals Image Figure 16. Specialty Clinics Image Figure 17. Other Image Figure 18. Global Crohn’s Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Crohn’s Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Crohn’s Disease Treatment Sales Value Share by Application (2021-2032) Figure 21. Global Crohn’s Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Crohn’s Disease Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Crohn’s Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. North America Crohn’s Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Crohn’s Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Crohn’s Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Crohn’s Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Crohn’s Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Crohn’s Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. South America Crohn’s Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Crohn’s Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Crohn’s Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids
  • Immunomodulators
  • Antibiotics
  • Amino Salicylates
  • Others
Applications
  • Hospitals
  • Specialty Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Ltd
  • Johnson & Johnson
  • Roche
  • Pfizer Inc.
  • Biogen
  • Bristol Myers Squibb
  • Abbvie Inc.
  • AstraZeneca
  • Prometheus Laboratories Inc. (Nestle)
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Crohn’s Disease Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Crohn’s Disease Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Crohn’s Disease Treatment Market Dynamics
  1. 2.1 Crohn’s Disease Treatment Industry Trends
  2. 2.2 Crohn’s Disease Treatment Industry Drivers
  3. 2.3 Crohn’s Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Crohn’s Disease Treatment Industry Restraints
3 Crohn’s Disease Treatment Market by Company
  1. 3.1 Global Crohn’s Disease Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Crohn’s Disease Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Crohn’s Disease Treatment Company Ranking (2024-2026)
  4. 3.4 Global Crohn’s Disease Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Crohn’s Disease Treatment Company Product Type and Application
  6. 3.6 Global Crohn’s Disease Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Crohn’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Crohn’s Disease Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Crohn’s Disease Treatment Market by Type
  1. 4.1 Crohn’s Disease Treatment Type Introduction
  2. 4.1.1 Corticosteroids
  3. 4.1.2 Immunomodulators
  4. 4.1.3 Antibiotics
  5. 4.1.4 Amino Salicylates
  6. 4.1.5 Others
  7. 4.2 Global Crohn’s Disease Treatment Sales Value by Type
  8. 4.2.1 Global Crohn’s Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Crohn’s Disease Treatment Sales Value by Type (2021-2032)
  10. 4.2.3 Global Crohn’s Disease Treatment Sales Value Share by Type (2021-2032)
5 Crohn’s Disease Treatment Market by Application
  1. 5.1 Crohn’s Disease Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Specialty Clinics
  4. 5.1.3 Other
  5. 5.2 Global Crohn’s Disease Treatment Sales Value by Application
  6. 5.2.1 Global Crohn’s Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Crohn’s Disease Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Crohn’s Disease Treatment Sales Value Share by Application (2021-2032)
6 Crohn’s Disease Treatment Regional Value Analysis
  1. 6.1 Global Crohn’s Disease Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Crohn’s Disease Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Crohn’s Disease Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Crohn’s Disease Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Crohn’s Disease Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Crohn’s Disease Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Crohn’s Disease Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Crohn’s Disease Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Crohn’s Disease Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Crohn’s Disease Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Crohn’s Disease Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Crohn’s Disease Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Crohn’s Disease Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Crohn’s Disease Treatment Sales Value Share by Country, 2025 VS 2032
7 Crohn’s Disease Treatment Country-level Value Analysis
  1. 7.1 Global Crohn’s Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Crohn’s Disease Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Crohn’s Disease Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Crohn’s Disease Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Crohn’s Disease Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Crohn’s Disease Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Crohn’s Disease Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Ltd
  2. 8.1.1 Takeda Pharmaceutical Ltd Company Information
  3. 8.1.2 Takeda Pharmaceutical Ltd Business Overview
  4. 8.1.3 Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Ltd Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Crohn’s Disease Treatment Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Crohn’s Disease Treatment Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Pfizer Inc.
  20. 8.4.1 Pfizer Inc. Company Information
  21. 8.4.2 Pfizer Inc. Business Overview
  22. 8.4.3 Pfizer Inc. Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc. Crohn’s Disease Treatment Product Portfolio
  24. 8.4.5 Pfizer Inc. Recent Developments
  25. 8.5 Biogen
  26. 8.5.1 Biogen Company Information
  27. 8.5.2 Biogen Business Overview
  28. 8.5.3 Biogen Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biogen Crohn’s Disease Treatment Product Portfolio
  30. 8.5.5 Biogen Recent Developments
  31. 8.6 Bristol Myers Squibb
  32. 8.6.1 Bristol Myers Squibb Company Information
  33. 8.6.2 Bristol Myers Squibb Business Overview
  34. 8.6.3 Bristol Myers Squibb Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bristol Myers Squibb Crohn’s Disease Treatment Product Portfolio
  36. 8.6.5 Bristol Myers Squibb Recent Developments
  37. 8.7 Abbvie Inc.
  38. 8.7.1 Abbvie Inc. Company Information
  39. 8.7.2 Abbvie Inc. Business Overview
  40. 8.7.3 Abbvie Inc. Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Abbvie Inc. Crohn’s Disease Treatment Product Portfolio
  42. 8.7.5 Abbvie Inc. Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Crohn’s Disease Treatment Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Prometheus Laboratories Inc. (Nestle)
  50. 8.9.1 Prometheus Laboratories Inc. (Nestle) Company Information
  51. 8.9.2 Prometheus Laboratories Inc. (Nestle) Business Overview
  52. 8.9.3 Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Product Portfolio
  54. 8.9.5 Prometheus Laboratories Inc. (Nestle) Recent Developments
  55. 8.10 Bausch Health
  56. 8.10.1 Bausch Health Company Information
  57. 8.10.2 Bausch Health Business Overview
  58. 8.10.3 Bausch Health Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bausch Health Crohn’s Disease Treatment Product Portfolio
  60. 8.10.5 Bausch Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst